CT Perfusion as an Imaging Biomarker in Monitoring Response to Neoadjuvant Bevacizumab and Radiation in Soft-Tissue Sarcomas: Comparison With Tumor Morphology, Circulating and Tumor Biomarkers, and Gene Expression

Kambadakone Avinash; Yoon Sam S.; Kim Tae-Min; Karl Daniel L.; Duda Dan G.; DeLaney Thomas F.; Sahani Dushyant V.

首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >CT Perfusion as an Imaging Biomarker in Monitoring Response to Neoadjuvant Bevacizumab and Radiation in Soft-Tissue Sarcomas: Comparison With Tumor Morphology, Circulating and Tumor Biomarkers, and Gene Expression

【24h】

CT Perfusion as an Imaging Biomarker in Monitoring Response to Neoadjuvant Bevacizumab and Radiation in Soft-Tissue Sarcomas: Comparison With Tumor Morphology, Circulating and Tumor Biomarkers, and Gene Expression

机译：CT灌注作为成像生物标志物，监测对软组织肉瘤对新辅助贝伐单抗和放射的反应：与肿瘤形态学，循环和肿瘤生物标志物以及基因表达的比较

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE. The purpose of this study was to evaluate the role of CT perfusion in monitoring response to neoadjuvant antiangiogenic and radiation therapy in resectable soft-tissue-sarcomas and correlate the findings with tumor size, circulating and tumor biomarkers, and gene expression.

机译：目的。这项研究的目的是评估CT灌注在监测可切除的软组织肉瘤对新辅助抗血管生成和放射治疗的反应中的作用，并将研究结果与肿瘤大小，循环和肿瘤生物标志物以及基因表达相关联。

著录项

来源
《AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences》 |2015年第1期|共8页
作者
Kambadakone Avinash; Yoon Sam S.; Kim Tae-Min; Karl Daniel L.; Duda Dan G.; DeLaney Thomas F.; Sahani Dushyant V.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词
bevacizumab; CT perfusion; radiation therapy; soft-tissue sarcoma;

机译：贝伐单抗;CT灌注;放射治疗;软组织肉瘤;

相似文献

外文文献
中文文献
专利

1. 奥沙利铂和卡培他滨联合贝伐单抗加放疗的新辅助方案治疗局部晚期直肠癌:单中心Ⅱ期研究结果 [J] . Xin Yu, De-sen Wan, Pei-rong Ding, 癌症（英文版） . 2018,第008期
2. CT Perfusion as an Imaging Biomarker in Monitoring Response to Neoadjuvant Bevacizumab and Radiation in Soft-Tissue Sarcomas: Comparison With Tumor Morphology, Circulating and Tumor Biomarkers, and Gene Expression [J] . Kambadakone Avinash, Yoon Sam S., Kim Tae-Min, AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences . 2015,第1期

机译：CT灌注作为成像生物标志物，监测对软组织肉瘤对新辅助贝伐单抗和放射的反应：与肿瘤形态学，循环和肿瘤生物标志物以及基因表达的比较
3. Evaluating the response of neoadjuvant chemotherapy for treatment of breast cancer: are tumor biomarkers and dynamic contrast enhanced MR images useful predictive tools? [J] . Zijing Zhang, Wei Zhang, Yiting Jin, Journal of Thoracic Disease . 2014,第6期

机译：评估新辅助化疗对乳腺癌的反应：肿瘤生物标志物和动态对比增强的MR图像是否有用的预测工具？
4. Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers [J] . Wenyong Tan, Ming Yang, Hongli Yang, Cancer Management and Research . 2018,第2016期

机译：预测早期乳腺癌对新辅助疗法的反应：肿瘤，血液和影像学相关的生物标志物
5. OPTIMIZING METRONOMIC CHEMOTHERAPY USING TUMOR BIOMARKERS IN DOGS WITH SOFT TISSUE SARCOMA [C] . Jenna Burton, Dahlia Rice, Jesse Harper, Annual Conference of the Veterinary Cancer Society . 2009

机译：用软组织肉瘤患者肿瘤生物标志物优化元组化疗
6. Imaging Biomarkers of Response to Radiation and Anti-angiogenic Agents in Brain Tumors. [D] . Chung, Caroline. 2011

机译：在脑肿瘤中对放射和抗血管生成剂的反应的生物标志物成像。
7. CT Perfusion as an Imaging Biomarker in Monitoring Response to Neoadjuvant Bevacizumab and Radiation in Soft-Tissue Sarcomas: Comparison With Tumor Morphology Circulating and Tumor Biomarkers and Gene Expression [O] . Avinash Kambadakone, Sam S. Yoon, Tae-Min Kim, -1

机译：CT灌注作为成像生物标志物用于监测对软组织肉瘤新辅助贝伐单抗和放射的反应：与肿瘤形态学循环和肿瘤生物标志物以及基因表达的比较
8. CT Perfusion as an Imaging Biomarker in Monitoring Response to Neoadjuvant Bevacizumab and Radiation in Soft-Tissue Sarcomas: Comparison With Tumor Morphology, Circulating and Tumor Biomarkers, and Gene Expression [O] . Avinash Kambadakone, Sam S. Yoon, Tae-Min Kim, 2015

机译：CT灌注作为一种成像生物标志物，用于监测对新辅助的贝伐单抗和软组织肉瘤中的辐射的响应：与肿瘤形态，循环和肿瘤生物标志物的比较，以及基因表达

CT Perfusion as an Imaging Biomarker in Monitoring Response to Neoadjuvant Bevacizumab and Radiation in Soft-Tissue Sarcomas: Comparison With Tumor Morphology, Circulating and Tumor Biomarkers, and Gene Expression

摘要

著录项

相似文献

相关主题

期刊订阅